Share prices of India's largest drug maker Ranbaxy Laboratories gained 9.08 percent on the Bombay Stock Exchange (BSE) after the company confirmed in a regulatory statement Wednesday that the US Department of Justice (DoJ) has withdrawn its legal motion against it.8:01 PM on October 08
Be the first to comment...
Add Your Comment